Organovo Statistics
Share Statistics
Organovo has 15.37M shares outstanding. The number of shares has increased by 53.04% in one year.
| Shares Outstanding | 15.37M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.01% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 15.07M |
| Failed to Deliver (FTD) Shares | 14.98K |
| FTD / Avg. Volume | 7.32% |
Short Selling Information
The latest short interest is 114.82K, so 0.75% of the outstanding shares have been sold short.
| Short Interest | 114.82K |
| Short % of Shares Out | 0.75% |
| Short % of Float | 0.76% |
| Short Ratio (days to cover) | 0.42 |
Valuation Ratios
The PE ratio is -0.64 and the forward PE ratio is -0.48.
| PE Ratio | -0.64 |
| Forward PE | -0.48 |
| PS Ratio | 86.42 |
| Forward PS | 26.8 |
| PB Ratio | 2.62 |
| P/FCF Ratio | -0.64 |
| PEG Ratio | n/a |
Enterprise Valuation
Organovo Inc. has an Enterprise Value (EV) of 5.59M.
| EV / Earnings | -0.38 |
| EV / Sales | 51.24 |
| EV / EBITDA | -0.38 |
| EV / EBIT | -0.37 |
| EV / FCF | -0.38 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.12 |
| Quick Ratio | 1.96 |
| Debt / Equity | 0.14 |
| Total Debt / Capitalization | 12.32 |
| Cash Flow / Debt | -28.96 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -4.07% and return on capital (ROIC) is -302.06%.
| Return on Equity (ROE) | -4.07% |
| Return on Assets (ROA) | -2.31% |
| Return on Capital (ROIC) | -302.06% |
| Revenue Per Employee | 9.08K |
| Profits Per Employee | -1.22M |
| Employee Count | 12 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 2.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -67.29% in the last 52 weeks. The beta is 0.61, so Organovo 's price volatility has been higher than the market average.
| Beta | 0.61 |
| 52-Week Price Change | -67.29% |
| 50-Day Moving Average | 0.41 |
| 200-Day Moving Average | 0.65 |
| Relative Strength Index (RSI) | 41.19 |
| Average Volume (20 Days) | 204.54K |
Income Statement
In the last 12 months, Organovo had revenue of 109.00K and earned -14.67M in profits. Earnings per share was -1.6.
| Revenue | 109.00K |
| Gross Profit | 109.00K |
| Operating Income | -15.09M |
| Net Income | -14.67M |
| EBITDA | -14.81M |
| EBIT | -15.09M |
| Earnings Per Share (EPS) | -1.6 |
Balance Sheet
The company has 2.90M in cash and 1.39M in debt, giving a net cash position of 1.51M.
| Cash & Cash Equivalents | 2.90M |
| Total Debt | 1.39M |
| Net Cash | 1.51M |
| Retained Earnings | -339.67M |
| Total Assets | 6.75M |
| Working Capital | 2.37M |
Cash Flow
In the last 12 months, operating cash flow was -14.65M and capital expenditures -42.00K, giving a free cash flow of -14.70M.
| Operating Cash Flow | -14.65M |
| Capital Expenditures | -42.00K |
| Free Cash Flow | -14.70M |
| FCF Per Share | -1.61 |
Margins
Gross margin is 100%, with operating and profit margins of -13.84K% and -13.46K%.
| Gross Margin | 100% |
| Operating Margin | -13.84K% |
| Pretax Margin | -13.46K% |
| Profit Margin | -13.46K% |
| EBITDA Margin | -13.58K% |
| EBIT Margin | -13.84K% |
| FCF Margin | -13.48K% |
Dividends & Yields
ONVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -457.14% |
| FCF Yield | -272.85% |
Analyst Forecast
Currently there are no analyst rating for ONVO.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 19, 2020. It was a backward split with a ratio of 1:20.
| Last Split Date | Aug 19, 2020 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -76.11 |
| Piotroski F-Score | 2 |